Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
This study is currently recruiting participants.
Study NCT00776594 Information provided by Dana-Farber Cancer Institute
First Received: October 20, 2008 Last Updated: December 16, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Additional conditions recognized in this trial
Prostatic Neoplasms
Recurrence
More general conditions related to this trial
Disease Attributes
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Pathologic Processes
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
Androgen Deprivation Therapy
bicalutamide
bevacizumab
Additional drug interventions recognized in this trial
Androgens
More general drug interventions related to this trial
Androgen Antagonists
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Hormone Antagonists
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Dana-Farber Cancer Institute
Genentech
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Back to top of Main Content
